VENTYX BIOSCIENCES INC's ticker is and the CUSIP is 92332V107. A total of 47 filers reported holding VENTYX BIOSCIENCES INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $46,641,591 | +5.4% | 1,342,977 | -0.5% | 0.01% | +12.5% |
| Q2 2023 | $44,267,930 | +51.8% | 1,349,632 | +55.0% | 0.01% | +33.3% |
| Q1 2023 | $29,161,918 | +45.7% | 870,505 | +42.6% | 0.01% | +50.0% |
| Q4 2022 | $20,010,851 | -28.1% | 610,273 | -23.5% | 0.00% | -33.3% |
| Q3 2022 | $27,839,000 | +153.6% | 797,445 | -11.2% | 0.01% | +200.0% |
| Q2 2022 | $10,978,000 | -46.0% | 897,621 | -40.3% | 0.00% | -33.3% |
| Q1 2022 | $20,321,000 | -43.0% | 1,502,971 | -17.8% | 0.00% | -50.0% |
| Q4 2021 | $35,666,000 | – | 1,828,528 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 2,298,833 | $77,010,906 | 42.68% |
| Qiming U.S. Ventures Management, LLC | 746,370 | $25,003,395 | 30.26% |
| TCG Crossover Management, LLC | 815,724 | $27,326,754 | 5.33% |
| ACUTA CAPITAL PARTNERS, LLC | 208,500 | $6,984,750 | 5.15% |
| Affinity Asset Advisors, LLC | 260,008 | $8,710,268 | 2.88% |
| Avidity Partners Management LP | 1,917,800 | $64,246,300 | 2.13% |
| Integral Health Asset Management, LLC | 290,000 | $9,715,000 | 1.96% |
| Tri Locum Partners LP | 152,842 | $5,120,207 | 1.56% |
| Vivo Capital, LLC | 602,075 | $20,169,513 | 1.40% |
| Boxer Capital, LLC | 850,000 | $28,475 | 1.40% |